Covance competitors

Covance's competitors include Otonomy, MyoKardia, Athersys and Shire
Add company...
Covance
Covance, the drug development business of Laboratory Corporation of America Holdings (LabCorp), is the world's most comprehensive drug development company.
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
MyoKardia
MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.
Athersys
Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.
Shire
Shire is a specialty biopharmaceutical company.
Founding Date
Founding Date
1968
Founding Date
2008
Founding Date
2012
Founding Date
1995
Founding Date
1986
Type
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Princeton, US HQ
Locations
San Diego, US HQ
Locations
South San Francisco, US HQ
Locations
Cleveland, US HQ
Canton, US
Locations
Dublin, IE HQ
Buenos Aires, AR
Sydney, AU
Wien, AT
Bruxelles, BE
Chácara Santo Antonio (Zona Sul), BR
Sofia, BG
see more
Employees
Employees
N/A
Employees
139
Employees
1024% increase
Employees
60
Employees
23,0444% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
82.7 m
Valuation ($)
2.5 b
Valuation ($)
268.9 m
Valuation ($)
46.6 b
Facebook likes
Facebook likes
3.8 k
Facebook likes
1.1 k
Facebook likes
N/A
Facebook likes
475
Facebook likes
N/A
Twitter followers
Twitter followers
8 k
Twitter followers
267
Twitter followers
387
Twitter followers
953
Twitter followers
6.2 k

Financial

Revenue (est.)
Revenue (est.)
$2.6b (FY, 2013)
Revenue (est.)
$1.2m (FY, 2017)
Revenue (est.)
$22.5m (FY, 2017)
Revenue (est.)
$3.7m (FY, 2017)
Revenue (est.)
$15.2b (FY, 2017)
Cost of goods
Cost of goods
N/A
Cost of goods
$3.1m (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$4.7b (FY, 2017)
Gross profit
Gross profit
N/A
Gross profit
($1.9m) (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Gross profit
$10.5b (FY, 2017)
Net income
Net income
$179.2m (FY, 2013)
Net income
($90.1m) (FY, 2017)
Net income
($46m) (FY, 2017)
Net income
N/A
Net income
$4.3b (FY, 2017)

Operating

Patents (US)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
4 (FY, 2017)
Patents (US)
21 (FY, 2016)
Patents (US)
N/A
Patents Issued
Patents Issued
N/A
Patents Issued
88 (FY, 2016)
Patents Issued
N/A
Patents Issued
200 (FY, 2016)
Patents Issued
N/A
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
1 (FY, 2016)
Phase I Trials Products
2 (FY, 2017)
Phase I Trials Products
N/A
Phase I Trials Products
7 (FY, 2017)
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
2 (FY, 2016)
Phase II Trials Products
1 (FY, 2017)
Phase II Trials Products
N/A
Phase II Trials Products
10 (FY, 2017)
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
2 (FY, 2016)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
15 (FY, 2017)
Preclinical Phase Products
Preclinical Phase Products
N/A
Preclinical Phase Products
1 (FY, 2016)
Preclinical Phase Products
3 (FY, 2017)
Preclinical Phase Products
N/A
Preclinical Phase Products
35 (FY, 2017)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 153.4m
Total funding raised
$ 98m
Total funding raised
$ 9m
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Otonomy
HQ
San Diego, US
Employees
139

Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.

View company
MyoKardia
HQ
South San Francisco, US
Employees
102↑ 4% increase

MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

View company
Athersys
HQ
Cleveland, US
Employees
60

Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.

View company
Shire
HQ
Dublin, IE
Employees
23,044↓ 4% decrease

Shire is a specialty biopharmaceutical company.

View company